Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia

NCT07232953 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukaemia (AML)
Hematopoietic Stem Cell Transplant (HSCT)

Interventions

DRUG: Fludarabine + Treosulfan

Sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia